1949, Arch Pathol, 48, 342
10.1016/B978-0-12-024912-1.50008-9
1991, Adv Exp Med Biol, 285, 373
10.1007/978-3-642-76849-1_1
1991, Atheroscler Rev, 23, 91
10.1161/atv91.14.5.8172861
10.1056/NEJM197608122950707
10.1056/NEJM197608192950805
1977, Am J Pathol, 86, 675
10.1016/0163-7827(86)90074-3
10.1097/00041433-199310000-00004
1992, Am J Pathol, 140, 907
10.1111/j.1749-6632.1990.tb42271.x
10.1161/atv91.12.9.1525124
1992, Arch Pathol Lab Med, 116, 1301
10.1161/atv91.13.8.8343497
1992, Arch Pathol Lab Med, 116, 1292
1957, Arch Pathol, 64, 303
10.1111/j.1749-6632.1990.tb42282.x
10.1161/atv91.12.12.1450173
10.1016/0021-9150(92)90045-I
10.1161/atv91.13.8.8343494
10.1161/atv91.14.2.8305425
10.1097/00041433-199408000-00002
1913, Zentralbl Allg Pathol, 24, 1
1989, Ann Cardiol Angeiol (Paris), 38, 631
10.1016/0002-9149(93)90863-8
10.1161/atv91.13.9.8364021
1984, Am J Pathol, 114, 112
10.1016/0014-4800(89)90018-X
10.1161/atv91.12.4.1558836
Kreuzer J Lloyd MB Bok D Fless GM Scanu AM Lusis AJ Haberland ME. Lipoprotein (a) displays increased accumulation compared with low-density lipoprotein in the murine arterial wall. Chem Phys Lipids . 1994;67/68:175-190.
10.1161/atv91.12.11.1420090
10.1161/atv91.12.11.1420091
1994, Am J Pathol, 144, 952
10.1161/atv91.13.2.7678986
10.1161/atv91.11.6.1931881
10.1161/atv91.14.3.8123647
1993, Lab Invest, 68, 369
1991, Am J Pathol, 139, 101
10.1161/atv91.12.11.1420084
10.1016/S0006-3495(93)81498-X
10.1016/0305-0491(71)90234-3
10.1161/atv91.14.1.8274468
1983, Am J Pathol, 113, 156
10.1016/0021-9150(86)90143-7
10.1016/0021-9150(88)90078-0
10.1161/atv91.14.1.8274466
1988, Am J Pathol, 131, 73
1986, Am J Pathol, 123, 109
10.1097/00041433-199010000-00006
10.1097/00041433-199310000-00007
Chisolm GM. Antioxidants and atherosclerosis: a current assessment. Clin Cardiol . 1991;14(2 suppl 1):I25-I30.
10.1161/circ.85.6.1591855
10.1016/0005-2760(86)90343-7
10.1016/0006-2952(88)90126-8
1991, J Lipid Res, 32, 243, 10.1016/S0022-2275(20)42085-1
10.1016/0005-2760(92)90310-R
10.1016/0005-2760(92)90256-U
10.1016/0005-2760(93)90076-L
1993, J Biol Chem, 268, 18502, 10.1016/S0021-9258(17)46655-5
1991, J Biol Chem, 266, 2282, 10.1016/S0021-9258(18)52241-9
1992, J Lipid Res, 33, 1315, 10.1016/S0022-2275(20)40545-0
1987, J Biol Chem, 262, 10098, 10.1016/S0021-9258(18)61082-8
1993, J Lipid Res, 34, 1219, 10.1016/S0022-2275(20)37709-9
10.1161/atv91.12.5.1576119
10.1161/atv91.13.11.7692957
10.1161/atv91.14.1.7506053
10.1016/0140-6736(92)90926-T
10.1056/NEJM199404143301501
Lund G Beisiegel U Seeber N Nikutta P Hamm CW. Effect of probucol on progression/regression of coronary artery disease. In: Abstracts Submitted to the Council on Arteriosclerosis for the 66th Scientific Sessions of the American Heart Association . Dallas Tex: American Heart Association Inc; 1993:124.
10.1097/00041433-199408000-00004
10.1161/atv91.14.5.8172860
10.1161/atv91.11.5.1911712
10.1096/fasebj.4.6.2318380
10.1161/atv91.12.5.1576122
10.1016/0021-9150(88)90097-4
10.1001/jama.1978.03290010051023
10.1161/atv91.13.12.8241102
10.1161/atv91.14.7.8018672
10.1016/S0140-6736(81)92346-1
10.1016/0009-8981(89)90151-4
10.1016/0141-8130(90)90081-K
Ehnholm C Jauhiainen M Metso J. Interaction of lipoprotein(a) with fibronectin and its potential role in atherogenesis. Eur Heart J . 1990;11(suppl E):190-195.
10.1016/0021-9150(77)90057-0
Williams KJ Fless GM Petrie K Snyder ML Brocia RW Swenson TL. Lipoprotein lipase enhances cellular catabolism of lipoprotein(a). Circulation . 1991;84(suppl II):II-566. Abstract.
1992, J Biol Chem, 267, 13284, 10.1016/S0021-9258(18)42208-9
1993, J Biol Chem, 268, 9369, 10.1016/S0021-9258(18)98359-6
1993, J Biol Chem, 268, 20419, 10.1016/S0021-9258(20)80745-5
1970, J Lipid Res, 11, 23, 10.1016/S0022-2275(20)43012-3
1991, J Biol Chem, 266, 24849, 10.1016/S0021-9258(18)54306-4
Schissel SL Williams KJ Tabas I. Sphingomyelinase (SMase)-induced LDL aggregation: mechanism and relevance. Circulation . 1994;90(pt 2):I-403. Abstract.
10.1016/0021-9150(71)90035-9
10.1016/S0022-2275(20)38694-6
10.1016/0021-9150(94)90010-8
10.1111/j.1365-2362.1989.tb00193.x
Kostner GM Bihari-Varga M. Is the atherogenicity of Lp(a) caused by its reactivity with proteoglycans? Eur Heart J . 1990;11(suppl E):184-189.
Williams KJ Swenson TL Brocia RW Rothman VL Tuszynski GP Fisher EA. Involvement of the syndecan family of heparan sulfate proteoglycans (HSPGs) in cellular uptake of complexes of lipoprotein lipase (LpL) with lipoproteins. Circulation . 1993;88(suppl I):I-365. Abstract.
1994, J Lipid Res, 35, 1152, 10.1016/S0022-2275(20)39957-0
10.1161/atv91.13.2.8427855
10.1016/0021-9150(92)90130-9
10.1016/0140-6736(93)93129-O
Dugi KA Feuerstein IM Santamarina-Fojo S Brewer HB Jr Hoeg JM. Lipoprotein lipase may contribute to the variant degree of atherosclerosis in homozygous familial hypercholesterolemia. Circulation . 1994;90(pt 2):I-405. Abstract.
1986, Lab Invest, 54, 402
1994, Am J Pathol, 144, 538
10.1111/j.1749-6632.1985.tb11857.x
10.1161/atv91.12.2.1543697
10.1016/0014-5793(90)80857-F
10.1016/S0021-9258(17)41834-5
1994, J Biol Chem, 269, 17606, 10.1016/S0021-9258(17)32484-5
10.1016/S0022-2275(20)43166-9
10.1161/atv91.12.8.1637798
10.1016/0005-2760(87)90143-3
10.1016/S0005-2728(88)80087-2
1993, J Biol Chem, 268, 11951, 10.1016/S0021-9258(19)50292-7
1993, Am J Pathol, 142, 1787
10.1161/atv91.11.6.1931877
10.1016/0040-8166(88)90026-2
10.1097/00004872-198900076-00054
1981, J Immunol, 126, 1510, 10.4049/jimmunol.126.4.1510
10.1016/0021-9150(88)90300-0
10.1016/0021-9150(90)90072-Q
1993, J Biol Chem, 268, 14131, 10.1016/S0021-9258(19)85218-3
10.1161/atv91.13.9.8364022
1993, J Biol Chem, 268, 14812, 10.1016/S0021-9258(18)82406-1
10.1111/j.1399-0004.1978.tb02058.x
10.1016/0021-9150(90)90088-Z
10.1097/00041433-199110000-00008
1993, J Biol Chem, 268, 8569, 10.1016/S0021-9258(18)52913-6
10.1161/atv91.14.8.8049196
1993, J Biol Chem, 268, 4709, 10.1016/S0021-9258(18)53454-2
10.1016/S0021-9258(18)52266-3
10.1016/0049-3848(92)90080-T
10.1016/0049-3848(93)90236-H
Edelberg J Pizzo SV. Lipoprotein (a) regulates plasmin generation and inhibition. Chem Phys Lipids . 1994;67/68:363-368.
10.1093/clinchem/30.7.1125
1991, J Biol Chem, 266, 23274, 10.1016/S0021-9258(18)54493-8
1992, J Biol Chem, 267, 4870, 10.1016/S0021-9258(18)42911-0
10.1016/S0021-9258(19)88721-5
1990, Eur J Cell Biol, 52, 98
1992, Eur J Cell Biol, 59, 314
1992, J Biol Chem, 267, 15729, 10.1016/S0021-9258(19)49596-3
1993, J Biol Chem, 268, 18740, 10.1016/S0021-9258(17)46692-0
1994, Am J Pathol, 144, 1348
1994, J Biol Chem, 269, 10438, 10.1016/S0021-9258(17)34079-6
1994, J Biol Chem, 269, 2270, 10.1016/S0021-9258(17)42164-8
1994, J Biol Chem, 269, 19295, 10.1016/S0021-9258(17)32166-X
1994, J Biol Chem, 269, 21204, 10.1016/S0021-9258(17)31949-X
1993, J Biol Chem, 268, 20091, 10.1016/S0021-9258(20)80698-X
10.1097/00041433-199404000-00008
Shimano H Yamada N Ohsuga J Shimada M Yazaki Y. Anti-atherogenic effect of apolipoprotein E is mediated through enhanced cholesterol efflux in transgenic mice. Circulation . 1993;88(suppl I):I-421. Abstract.
10.1016/S0140-6736(76)92650-7
1990, J Lipid Res, 31, 645, 10.1016/S0022-2275(20)42832-9
10.1016/0014-5793(89)81590-X
10.1161/circ.82.2.2372896
Camejo G Hurt E Thubrikar M Bondjers G. Modification of low density lipoprotein association with the arterial intima: a possible environment for the antiatherogenic action of beta-blockers. Circulation . 1991;84(suppl VI):VI-17-VI-22.
10.1161/atv91.14.3.8123657
10.1016/0021-9150(85)90169-8
1993, Am J Pathol, 143, 1551
Chen J-K Hoshi H McKeehan WL. Stimulation of human arterial smooth muscle cell chondroitin sulfate proteoglycan synthesis by transforming growth factor-beta. In Vitro Cell Dev Biol . 1991;27A:6-12.
10.1016/0021-9150(90)90073-R
10.1016/0005-2760(91)90204-U
Hurt-Camejo E Camejo G Rosengren B Bondjers G. LDL binding to matrix proteoglycans from smooth muscle cells is modulated by cell secreted and martix bound phospholipase A 2 . Circulation . 1994;90(pt 2):I-403. Abstract.
10.1161/atv91.14.9.8068605
10.1016/0021-9150(89)90217-7
10.1161/atv91.13.5.8485115
10.1016/0143-4160(88)90008-5
10.1016/S0735-1097(85)80265-5
